0001628280-26-047710.txt : 20260708 0001628280-26-047710.hdr.sgml : 20260708 20260708184919 ACCESSION NUMBER: 0001628280-26-047710 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260708 FILED AS OF DATE: 20260708 DATE AS OF CHANGE: 20260708 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stengone Carmine N. CENTRAL INDEX KEY: 0001861519 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42001 FILM NUMBER: 261163521 MAIL ADDRESS: STREET 1: 3565 GENERAL ATOMICS COURT STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Contineum Therapeutics, Inc. CENTRAL INDEX KEY: 0001855175 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 271467257 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3565 GENERAL ATOMICS COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 333-5280 MAIL ADDRESS: STREET 1: 3565 GENERAL ATOMICS COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Pipeline Therapeutics, Inc. DATE OF NAME CHANGE: 20210405 4 1 wk-form4_1783550956.xml FORM 4 X0609 4 2026-07-08 0 0001855175 Contineum Therapeutics, Inc. CTNM 0001861519 Stengone Carmine N. false 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121 1 1 0 0 CEO and President 1 Class A Common Stock 2026-07-08 4 M 0 2500 1.01 A 19717 D Class A Common Stock 2026-07-08 4 S 0 2500 16 D 17217 D Stock Option (right to buy) 1.01 2026-07-08 4 M 0 2500 0 D 2030-02-24 Class A Common Stock 2500 279430 D These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025. Options granted under the Issuer's 2012 Equity Incentive Plan (the "Plan"). The option is fully vested. /s/ Peter Slover, Attorney-in-Fact 2026-07-08